# High-contrast ZZ interaction using superconducting qubits with opposite-sign anharmonicity

Article · Peng Zhao, Peng Xu, Dong Lan, Ji Chu, Xinsheng Tan, Haifeng Yu, Yang Yu

- Archive id: arxiv:2002.07560
- Published: 2020-02-18
- Venue: Phys. Rev. Lett. 125, 200503 (2020)
- DOI: https://doi.org/10.1103/physrevlett.125.200503
- arXiv: https://arxiv.org/abs/2002.07560
- Citations: 94
- Source URL: https://arxiv.org/abs/2002.07560
- PDF: https://arxiv.org/pdf/2002.07560
- Provenance: arxiv

## Abstract

For building a scalable quantum processor with superconducting qubits, ZZ interaction is of great concern because its residual has a crucial impact to two-qubit gate fidelity. Two-qubit gates with fidelity meeting the criterion of fault-tolerant quantum computationhave been demonstrated using ZZ interaction. However, as the performance of quantum processors improves, the residual static-ZZ can become a performance-limiting factor for quantum gate operation and quantum error correction. Here, we introduce a superconducting architecture using qubits with opposite-sign anharmonicity, a transmon qubit and a C-shunt flux qubit, to address this issue. We theoretically demonstrate that by coupling the two types of qubits, the high-contrast ZZ interaction can be realized. Thus, we can control the interaction with a high on/off ratio to implement two-qubit CZ gates, or suppress it during two-qubit gate operation using XY interaction (e.g., an iSWAP gate). The proposed architecture can also be scaled up to multi-qubit cases. In a fixed coupled system, ZZ crosstalk related to neighboring spectator qubits could also be heavily suppressed.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Superconducting Quantum Processors](https://space-kitty.com/topics/superconducting-qubits)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.